Gross Profit - Nanjing Vazyme Biotech Co Ltd (SSE:688105) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 24.64 CNY -1.28%

Updated:

Nanjing Vazyme Biotech Co Ltd
Gross Profit

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

|

Adjust for Inflation

Nanjing Vazyme Biotech Co Ltd
Gross Profit Peer Comparison

6160

1801

603392

300122

300896

Company		Gross Profit	CAGR 3Y	CAGR 5Y	CAGR 10Y
N	Nanjing Vazyme Biotech Co Ltd SSE:688105	Gross Profit ¥771.1m	CAGR 3-Years -18%	CAGR 5-Years 41%	CAGR 10-Years N/A
	Beigene Ltd HKEX:6160	Gross Profit ¥14.7B	CAGR 3-Years 108%	CAGR 5-Years 67%	CAGR 10-Years N/A
	Innovent Biologics Inc HKEX:1801	Gross Profit ¥5.1B	CAGR 3-Years 14%	CAGR 5-Years N/A	CAGR 10-Years N/A
	Beijing Wantai Biological Pharmacy Enterprise Co Ltd SSE:603392	Gross Profit ¥4.5B	CAGR 3-Years 34%	CAGR 5-Years 45%	CAGR 10-Years N/A
	Chongqing Zhifei Biological Products Co Ltd SZSE:300122	Gross Profit ¥13.6B	CAGR 3-Years 28%	CAGR 5-Years 33%	CAGR 10-Years 40%
	Imeik Technology Development Co Ltd SZSE:300896	Gross Profit ¥1.8B	CAGR 3-Years 53%	CAGR 5-Years 57%	CAGR 10-Years N/A

See Also

Based on the financial report for Dec 31, 2023, Nanjing Vazyme Biotech Co Ltd's Gross Profit amounts to 771.1m CNY.

Over the last year, the Gross Profit growth was -65%. The average annual Gross Profit growth rates for Nanjing Vazyme Biotech Co Ltd have been -18% over the past three years , 41% over the past five years .

Join more than 139,100+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.